2009
Intercell – accelerating innovation.
Brehme M.
N Biotechnol, 2009 Apr;25(4):181-4. Epub 2009 Feb 21.
2009
Charting the molecular network of the drug target Bcr-Abl.
Brehme M,
Hantschel O,
Colinge J,
Kaupe I,
Planyavsky M,
Köcher T,
Mechtler K,
Bennett KL,
Superti-Furga G.
Proc Natl Acad Sci USA, 2009 May 5;106(18): 7414-9. Epub 2009 Apr 20.
2009
Generation and biological activities of oxidized phospholipids.
Bochkov VN,
Oskolkova OV,
Birukov KG,
Levonen AL,
Binder CJ,
Stöckl J.
Antioxid Redox Signal, Epub 2009 Aug 17.
2009
Non-coding RNAs: A higher level of genome encoded information.
Barlow DP.
RNA Biol, 2009 Apr;6(2):93. Editorial.
2009
Experimental immunotherapeutic approaches for atherosclerosis.
Amir S,
Binder CJ.
Clin Immunol, Epub 2009 Aug 8.
2009
Report on EU-USA workshop: how systems biology can advance cancer research
Aebersold R,
Auffray C,
.
Mol Oncol, 2009 Feb;3(1):9-17.
2008
Plasma interleukin – 5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis.
Sämpi M,
Ukkola O,
Päivänsalo M,
Kesäniemi YA,
Binder CJ,
Hörkkö S.
J Am Coll Cardiol. 2008, Oct 21;52(17):1370–8.
2008
Identification of the human homolog of the imprinted mouse Air non-coding RNA.
Yotova IY,
Vlatkovic IM,
Pauler FM,
Warczok KE,
Ambros PF,
Oshimura M,
Theussl HC,
Gessler M,
Wagner EF,
Barlow DP.
Genomics 2008, Dec;92(6):464–73.
2008
Finally: The digital, democratic age of scientific abstracts.
Superti-Furga G,
Wieland F,
Cesareni G.
FEBS Lett., 2008 Apr 9;582(8):1169.
2008
Silencing and transcriptional properties of the imprinted Airn ncRNA are independent of the endogenous promoter.
Stricker SH,
Steenpass L,
Pauler FM,
Santoro F,
Latos PA,
Huang R,
Koerner MV,
Sloane MA,
Warczok KE,
Barlow DP.
The EMBO Journal 2008, 27, 3116–3128.
